Balugtod, Erlinda D.
HRN: 19-80-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/16/2025
CIPROFLOXACIN 500MG (TAB)
02/16/2025
02/23/2025
PO
500mg
BID
Complicated UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes